港股异动 | 第一太平(00142.HK)大涨逾10% 附属Indofood中期纯利增11.68%
格隆汇8月3日丨第一太平(00142.HK)午后一度涨至13%,现报1.79港元,涨10.49%,暂成交1560万港元,最新总市值77.8亿港元。第一太平(00142.HK)拥有50.1%权益附属公司Indofood在印尼交易所公布上半年业绩,综合净销售额按年升2%至39.38万亿印尼盾(下同),股东应占纯利增11.68%至2.84万亿盾。业内人士称,第一太平在过去几年成长乏力,利润也处于下行的趋势,导致资本市场表现并不理想。不过该公司估值很低,市值远低于净资产值,估值也远低于行业。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.